Omalizumab Dose-Related Efficacy in a Cohort of Children With Severe Food Allergy: OSAFA Observational Study.
Allergy · Apr 1, 2026
What's New: Higher monthly doses of omalizumab were associated with greater food desensitization in children with severe food allergy, independent of baseline IgE levels.
Read more →